Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19
Status:
Withdrawn
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
Randomized, placebo-controlled study to evaluate the safety, pharmacokinetics and efficacy of
a single dose of STI-1499 (COVI-GUARD™) in hospitalized patients with moderate COVID-19